Correlation Between Akero Therapeutics and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Atea Pharmaceuticals, you can compare the effects of market volatilities on Akero Therapeutics and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Atea Pharmaceuticals.
Diversification Opportunities for Akero Therapeutics and Atea Pharmaceuticals
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akero and Atea is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Atea Pharmaceuticals
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.53 times more return on investment than Atea Pharmaceuticals. However, Akero Therapeutics is 1.53 times more volatile than Atea Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 2,971 in Akero Therapeutics on August 29, 2024 and sell it today you would earn a total of 145.00 from holding Akero Therapeutics or generate 4.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Akero Therapeutics |
| Atea Pharmaceuticals |
Akero Therapeutics and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Atea Pharmaceuticals
The main advantage of trading using opposite Akero Therapeutics and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |